Cargando…
RBM38 is negatively regulated by miR-320b and enhances Adriamycin resistance in breast cancer cells
Breast cancer (BC) is a common type of malignant tumor that is frequently accompanied by drug resistance, which is a significant challenge in the treatment of BC. Adriamycin (ADM) is a commonly used drug for the treatment of BC. The aim of the present study was to demonstrate the association between...
Autores principales: | Ke, Jing, Ni, Kan, Xue, Huimin, Li, Jia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630814/ https://www.ncbi.nlm.nih.gov/pubmed/34868364 http://dx.doi.org/10.3892/ol.2021.13145 |
Ejemplares similares
-
Downregulated miR-130a enhances the sensitivity of acute myeloid leukemia cells to Adriamycin
por: Liu, Huimin, et al.
Publicado: (2020) -
The double face of miR-320: cardiomyocytes-derived miR-320 deteriorated while fibroblasts-derived miR-320 protected against heart failure induced by transverse aortic constriction
por: Zhang, Xudong, et al.
Publicado: (2021) -
MiR-367 negatively regulates apoptosis induced by adriamycin in osteosarcoma cells by targeting KLF4
por: Wang, Guang-Chao, et al.
Publicado: (2016) -
MiR-320b and miR-320d as Biomarkers to Predict and Participate in the Formation of Platinum Resistance in Ovarian Cancer Patients
por: Liu, Yuan-Yuan, et al.
Publicado: (2022) -
Mechanism of the enhancing effects of miR-93 on resistance of breast cancer MCF-7 cells to adriamycin
por: Wang, Qian, et al.
Publicado: (2018)